SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the first quarter ended March 31, 2025, and provided recent business updates.
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Seeking Alpha / 54 minutes ago 1 Views
Comments